Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK3117391 in Subjects With Rheumatoid Arthritis

NCT02965599 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
3
Enrollment
INDUSTRY
Sponsor class

Stopped The study was terminated following an internal review of the company's current research and development portfolio.

Conditions

Interventions

Sponsor

GlaxoSmithKline